Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 27.65
+0.25 (0.91%)
Oct 16, 2026, 4:59 PM CET
Embla Medical Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Embla Medical stock has a consensus rating of "Buy" and an average price target of kr 33.60. The average 1-year stock price forecast is 21.52% higher than the current stock price, while the lowest is kr 30.00 (+8.50%) and the highest is kr 40.00 (+44.67%).
Price Target: kr 33.60 (+21.52%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Embla Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
1.02B
from 928.69M
Increased by 9.78%
Revenue Next Year
1.09B
from 1.02B
Increased by 7.34%
EPS This Year
0.23
from 0.19
Increased by 26.26%
EPS Next Year
0.27
from 0.23
Increased by 13.98%
EPS and Forward PE are based on non-GAAP adjusted numbers.